Glucose metabolism and serotonin receptors in the frontotemporal lobe degeneration

Annals of Neurology - Tập 57 Số 2 - Trang 216-225 - 2005
M. Franceschi1, Davide Anchisi2, Oriana Pelati2, Marta Zuffi1, Mario Matarrese3, Rosa Maria Moresco3,4, Ferruccio Fazio3,2,4, Daniela Perani5
1Neurology Department, Santa Maria Clinic, Castellanza, Varese
2Istituto di Ricerca a Carattere Scientifico Hospital San Raffaele, Milan
3Istituto di Bioimmagini e Fisiologia Molecolare-Consiglio Nazionale delle Ricerche, Milan
4University Milano-Bicocca
5Vita-Salute H San Raffaele University, Milan, Italy

Tóm tắt

AbstractIn patients with the frontal variant of frontotemporal lobar degeneration (fv‐FTLD), behavioral abnormalities may vary from apathy with motor slowness (apathetic form) to disinhibition with agitation (disinhibited form). These clinical presentations may be related to specific regional cerebral dysfunction and to deficit in the serotoninergic system. We studied cerebral glucose uptake using 18F‐fluorodeoxyglucose and positron emission tomography in 18 patients fulfilling clinical criteria for fv‐FTLD and showing, respectively, an apathetic or disinhibited behavioral syndrome. In eight of these patients, we also evaluated the 5‐hydroxytryptamine‐2A receptor cerebral receptor distribution with [11C]MDL and positron emission tomography. We found a reduction of frontal glucose metabolism in the whole group of fv‐FTLD patients. Apathetic syndrome was associated with a prevalent dorsolateral and frontal medial hypometabolism, whereas the disinhibited syndrome demonstrated a selective hypometabolism in interconnected limbic structures (the cingulate cortex, hippocampus/amygdala, and accumbens nucleus). The in vivo measurements of [11C]MDL indicated a significant reduction of 5‐hydroxytryptamine‐2A receptors in orbitofrontal, frontal medial, and cingulate cortices. These 18F‐fluorodeoxyglucose positron emission tomography changes can be considered as specific functional markers of the different behavioral presentations in fv‐FTLD. The serotoninergic system dysfunction provides a rationale for therapeutic trials with selective serotonin reuptake inhibitors. Ann Neurol 2005;57:216–225

Từ khóa


Tài liệu tham khảo

10.1001/archneur.58.11.1803

10.1212/WNL.58.11.1615

10.1212/WNL.51.6.1546

10.1212/WNL.57.10.1756

10.1093/brain/115.6.1783

10.1159/000107315

10.1093/brain/120.6.1027

10.1002/1531-8249(200001)47:1<36::AID-ANA8>3.0.CO;2-L

10.1212/WNL.58.2.198

10.1136/jnnp.66.2.184

10.1212/WNL.58.11.1608

10.1002/gps.709

10.1212/WNL.54.12.2277

10.1212/WNL.41.9.1374

10.1016/S1053-8119(03)00346-X

10.1006/nimg.2002.1208

10.1002/ana.10669

10.1111/j.1749-6632.1990.tb16897.x

Nordberg A, 1992, Neuroreceptor changes in Alzheimer disease, Cerebrovasc Brain Metab Rev, 4, 303

10.1093/brain/116.3.497

10.1016/S0006-8993(98)00909-3

10.1007/978-3-642-79928-0_3

Yang Y, 2001, Frontotemporal dementia: evidence for impairment of ascending serotoninergic but not noradrenergic innervation. Immunocytochemical and quantitative study using a graph method, Acta Neuropathol (Berl), 101, 256, 10.1007/s004010000293

10.1159/000051219

10.1212/01.WNL.0000052685.09194.39

10.1111/j.2044-8341.1959.tb00467.x

10.1212/WNL.44.12.2308

Lawton M, 1969, Assessment of older people: self‐maintaining and instrumental activity of daily living, Gerontologist, 15, 179, 10.1093/geront/9.3_Part_1.179

10.1111/j.1532-5415.1995.tb05550.x

Banos JH, 2000, California Verbal Learning Test

Novelli G, 1986, Tre test clinici di memoria verbale a lungo termine, Taratura su soggetti normali, Arch Psicol Neurol Psich, 47, 278

Rey A, 1983, Reattivo della figura complessa

10.1007/BF02333660

Spinnler H, 1987, Standardizzazione e taratura italiana di test neuropsicologici, Ital J Neurol Sci

10.1007/BF01997792

Basso A, 1987, Raven's coloured progressive matrices: normative values on 305 adult normal controls, Funct Neurol, 2, 189

Ito H, 1998, PET imaging of central 5‐HT2A receptors with carbon‐11‐MDL 100,907, J Nucl Med, 39, 208

Mathis CA, 1996, Synthesis and preliminary in vivo evaluation of [11C]MDL 100907: a potent and selective radioligand for the 5‐HT2A receptor system, Med Chem Res, 6, 1

10.1016/S0969-8051(02)00353-0

10.1002/hbm.460020402

10.1006/nimg.1998.0381

Stuss DT, 1986, The frontal lobes

10.1006/nimg.1999.0463

10.1212/WNL.51.1.142

10.1212/WNL.35.12.1731

10.1192/bjp.170.2.150

Amaral DG, 1992, The amigdala: neurobiological aspects of emotion, memory and mental dysfunction, 1

10.1016/S0149-7634(02)00007-6

10.1016/S0197-4580(02)00045-3

10.1212/WNL.52.1.91

10.1006/nimg.2000.0619

10.1001/archpsyc.57.9.850

10.1007/s00213-002-1379-5

10.1159/000067021

Thông tin
Thông tin xuất bản

Annals of Neurology

Tập 57 Số 2

216-225

Thông tin tác giả